Avoidant/Restrictive Food Intake Disorder, also known as ARFID, is a relatively new diagnosis; it was only added to the DSMV in 2013, and little is known about its true prevalence rate or effective treatment options. Yet, as clinicians in the field we are seeing more and more clients present to treatment, at all levels of care, with ARFID symptoms. This presentation is intended to provide an overview of what we currently know about the symptoms and presentation of ARFID and which existing treatments show promise to eventually be validated as evidence based interventions.